TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood vessel disease: drug targeting inflammation shows promise
Disease control Not yet recruitingThis study tests a drug called secukinumab in 52 people with active, severe Takayasu arteritis, a rare disease that causes inflammation and narrowing of major blood vessels. The goal is to see if the drug can stop disease activity and allow patients to stop taking steroids. Parti…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Could a lung drug help heal blood vessels in rare artery disease?
Disease control Not yet recruitingThis study tests whether adding pirfenidone, a drug used for lung scarring, to standard treatment can improve blood vessel damage in people with Takayasu arteritis. About 92 adults aged 18-60 will receive either pirfenidone or a placebo for 6 months. The goal is to see if the dru…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC